Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
dermal filler
|
| gptkbp:administeredBy |
injection
|
| gptkbp:approvedBy |
European CE mark
|
| gptkbp:compatibleWith |
FDA (as of 2023)
|
| gptkbp:crossLinked |
Vycross technology
|
| gptkbp:effect |
up to 18-24 months
|
| https://www.w3.org/2000/01/rdf-schema#label |
Volux
|
| gptkbp:indication |
facial volume restoration
|
| gptkbp:launched |
2019
|
| gptkbp:mainIngredient |
hyaluronic acid
|
| gptkbp:manufacturer |
gptkb:Allergan
|
| gptkbp:partOf |
Juvéderm product line
|
| gptkbp:sideEffect |
tenderness
swelling bruising |
| gptkbp:usedFor |
chin augmentation
jawline contouring |
| gptkbp:bfsParent |
gptkb:Bocchus_I
|
| gptkbp:bfsLayer |
7
|